OGSIVEO 150 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC PVDC aluminium de 56 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930325285
  • CIP7 3032528
  • CIS 62795356
  • Registration number EU/1/25/1932

What the source publishes

Holder
MERCK EUROPE (PAYS-BAS)
Active ingredients
NIROGACÉSTAT, DIBROMHYDRATE DE NIROGACÉSTAT
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVC PVDC aluminium de 56 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2025-08-14
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930325285
{
  "cis": "62795356",
  "cip7": "3032528",
  "form": "comprimé pelliculé",
  "name": "OGSIVEO 150 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC PVDC aluminium de 56 comprimé(s)",
  "cip13": "3400930325285",
  "holder": "MERCK EUROPE (PAYS-BAS)",
  "routes": [
    "orale"
  ],
  "holders": [
    "MERCK EUROPE (PAYS-BAS)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2025-08-14",
  "compositions": [
    {
      "name": "NIROGACÉSTAT",
      "nature": "FT",
      "strength": "150 mg",
      "linkageNumber": "1",
      "substanceCode": "32964",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "DIBROMHYDRATE DE NIROGACÉSTAT",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "85711",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "OGSIVEO 150 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) thermoformée(s) PVC PVDC aluminium de 56 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2026-03-02",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": true,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "NIROGACÉSTAT",
    "DIBROMHYDRATE DE NIROGACÉSTAT"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/25/1932",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930325285"